Dr. Moorthy’s research focuses on liquid chromatography-tandem mass spectrometry assays for translational research. He is an expert in developing and validating analytical methods and their implementation for pediatric and adult clinical sample analysis.
As the weather turns warm, children and adults of all ages naturally gravitate toward outdoor activities. Many dream of the start of beach season and lazy days basking in the sun. But protecting skin from the sun’s radiation is an important aspect of preventing cancer, and the sun-protective habits developed during childhood could have lifelong impacts.
Today at the White House, President Obama welcomed guests, including Adam Resnick, PhD, representing The Children’s Hospital of Philadelphia, for a morning of remarks and discussions about what the Precision Medicine Initiative (PMI) has achieved to date, and how it can take the next steps into the new era of medicine that delivers the right treatment at the right time to the right person.
A new genetic study offers glimpses into how scientists might use gene-sequencing data to customize pediatric patients' cancer treatments. While investigating the biology of brain tumors in children, researchers at The Children's Hospital of Philadelphia found that crucial differences in how genes are mutated in a tumor may call for different treatments."
The Moorthy Lab focuses on liquid chromatography-tandem mass spectrometry assays for translational research. The lab evaluates and uses new tools and microsampling technologies to facilitate preclinical, translational, and clinical research.